Mobile Site
Font Size +/-
805.963.1648
661.325.4393
Physicians
Meetings
News
CRC publications
Partnerships
Awards
NewsLetters
Bakersfield
Lancaster
Lompoc
Oxnard
Paso Robles
San Luis Obispo
Santa Barbara
Santa Maria
Valencia
Visalia
CRC contributes to Ground-Breaking Research
Clinical Studies: Closed
Clinical Studies: Ongoing
Clinical Studies: Open Enrollment
Clinical Trial Results
Internships at CRC
Your Visit
Diseases
Treatments
Resources
« back
Research
CRC contributes to Ground-Breaking Research
Clinical Studies: Closed
Clinical Studies: Ongoing
Diabetic Retinopathy - Laser and Ranbizumab or Triamcinolone for Diabetic Macular Edema
Diabetic Retinopathy - Regeneron VEGF Trap-Eye for DME
Dry AMD - Complement Factor D
Retinal Vein Occlusion - Ranibizumab for CRVO
Wet AMD - CATT (Comparison of AMD Treatments Trial)
Wet AMD - HARBOR Trial
Clinical Studies: Open Enrollment
Clinical Trial Results
Internships at CRC
Your browser does not support JavaScript.
Clinical Studies: Ongoing
Diabetic Retinopathy - Laser and Ranbizumab or Triamcinolone for Diabetic Macular Edema
Diabetic Retinopathy - Regeneron VEGF Trap-Eye for DME
Dry AMD - Complement Factor D
Retinal Vein Occlusion - Ranibizumab for CRVO
Wet AMD - CATT (Comparison of AMD Treatments Trial)
Wet AMD - HARBOR Trial
© california retina consultants |
mobile site
|
site map
|
website design customsoft